技术文章

Structural Characteristics of Ergothioneine, OCTN1-Mediated Uptake by Skin Cells, and Antioxidant Mechanisms

Introduction

 

Ergothioneine (L-ergothioneine, EGT) is a sulfur-containing derivative of L-histidine. The ergothioneine biosynthetic systems identified to date are found primarily in certain bacteria and fungi. No corresponding complete de novo biosynthetic pathway has been identified in humans, and ergothioneine in the human body is obtained mainly through the diet.[2–4]

 

Although humans cannot synthesize ergothioneine, they express a transporter capable of taking up this molecule. This protein is encoded by the solute carrier family 22 member 4 gene (SLC22A4) and is commonly known as organic cation transporter novel type 1 (OCTN1). OCTN1 mediates the high-affinity, saturable transmembrane uptake of ergothioneine. Human epidermal keratinocytes also express OCTN1 and can take up and accumulate extracellular ergothioneine.[5,6]

 

This dependence on transporter-mediated uptake is related to the molecular structure of ergothioneine. Ergothioneine contains both a positively charged trimethylammonium group and a negatively charged carboxylate group. It therefore exists as a zwitterion under physiological conditions and is highly water-soluble, but does not readily enter the hydrophobic interior of the cell membrane by passive diffusion. Its sulfur-containing imidazole ring exists predominantly in the thione form, making the molecule more resistant to spontaneous oxidation than ordinary free thiols.[1,3]

 

After entering cells, ergothioneine can participate in electron-transfer reactions involving certain highly reactive radicals. In vitro chemical studies have also shown that it can bind monovalent copper and attenuate copper-catalyzed oxidation. In skin-cell models exposed to ultraviolet A (UVA), ergothioneine has been associated with enhanced nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant responses and improved glutathione-dependent defense capacity.[7–10]

 

1. Sources and Structure of Ergothioneine

 

1.1 Basic Chemical Identity

Ergothioneine has a CAS Registry Number of 497-30-3, a molecular formula of C₉H₁₅N₃O₂S, and a relative molecular mass of 229.30. Its structure consists of an L-histidine-derived carbon skeleton, a trimethylammonium group, a carboxylate group, and a sulfur-containing imidazole ring.[1]

Chemically, ergothioneine is classified as a sulfur-containing histidine betaine and may also be referred to as 2-mercaptohistidine trimethylbetaine. It is not a conventional proteinogenic amino acid and has not been formally classified as an essential vitamin for humans.[1,4]

 

The principal charged groups in the ergothioneine structure include:

① Trimethylammonium group: N⁺(CH₃)₃;

② Carboxylate group: COO⁻;

③ Sulfur-containing imidazole ring: predominantly present in the thione form under physiological conditions.

The simultaneous presence of positive and negative charges means that ergothioneine exists mainly as a zwitterion in aqueous solution.

 

 

 

1.2 Biological Sources and Biosynthetic Pathways

Certain bacteria and fungi are capable of synthesizing ergothioneine de novo. In the classical mycobacterial pathway, for example, L-histidine first undergoes successive methylation to form histidine betaine, known as hercynine. A sulfur-containing group is then introduced, followed by further enzymatic conversion to produce ergothioneine. The sulfur-containing substrates and specific enzyme systems used are not identical among different microorganisms.[2,3,14]

No complete pathway corresponding to these microbial biosynthetic systems has been identified in the human genome. Ergothioneine in the human body is derived mainly from food, with mushrooms being a particularly notable source among commonly consumed foods. After absorption, ergothioneine can enter cells through OCTN1 and may accumulate and be retained in certain tissues.[4,5]

 

1.3 Thiol–Thione Tautomerism and Chemical Stability

The sulfur-containing imidazole ring of ergothioneine undergoes thiol–thione tautomerism:

Thiol form: imidazole ring–SH

Thione form: imidazole ring C=S

 

At pH values close to physiological conditions, the equilibrium strongly favors the thione form. Compared with molecules containing free sulfhydryl groups, such as cysteine and reduced glutathione, the thione structure reduces the tendency of ergothioneine to undergo rapid autoxidation and form disulfide bonds.[3]

This stability allows ergothioneine to resist continuous depletion in ordinary aqueous environments while retaining the ability to participate in electron-transfer reactions under stronger oxidative conditions.

 

1.4 Zwitterionic Structure and Transmembrane Uptake

The interior of the cell membrane is composed of hydrophobic lipid chains. Small, neutral molecules with a certain degree of lipid solubility can enter cells relatively easily by passive diffusion, whereas charged and highly hydrated molecules generally require transporter proteins.

Ergothioneine contains stable positive and negative charges and has a strong hydration capacity, making it difficult for the molecule to enter the hydrophobic interior of the cell membrane freely. Heterologous OCTN1 expression experiments have shown that cells expressing this transporter accumulate ergothioneine to a marked extent, whereas cells lacking the corresponding transport capacity exhibit very low uptake.[5]

 

2. How OCTN1 Mediates Ergothioneine Uptake by Skin Cells

 

2.1 High-Affinity, Saturable Transmembrane Uptake

OCTN1 belongs to the solute carrier 22 family. A heterologous expression study published in 2005 identified ergothioneine as a high-affinity substrate of OCTN1. Its transport was concentration-dependent and saturable, with a measured Michaelis constant of approximately 21 μmol/L.[5]

The primary role of OCTN1 is to increase the intracellular concentration of bioavailable ergothioneine. It does not directly generate an antioxidant reaction; rather, it determines whether ergothioneine can effectively reach the intracellular environment.

 

2.2 Human Epidermal Keratinocytes Express OCTN1

Both human skin tissue and cultured human epidermal keratinocytes express OCTN1. After extracellular ergothioneine is taken up through OCTN1, it can accumulate within keratinocytes.[6]

In experiments simulating oxidative stress caused by solar ultraviolet radiation, ergothioneine accumulation was associated with the following changes:

 

Observed Parameter

Experimental Result

Intracellular reactive oxygen species-related signals

Decreased

Oxidative DNA damage

Reduced

Oxidative protein damage

Reduced

Oxidative lipid damage

Reduced

Apoptosis and cell death

Reduced

 

These findings indicate that OCTN1-mediated transmembrane uptake enables keratinocytes to accumulate and utilize exogenous ergothioneine.[6]

 

3. How Ergothioneine Participates in the Cellular Antioxidant Network

 

Reactive oxygen species (ROS) comprise a group of oxidizing species with different chemical properties. Superoxide anions and hydroxyl radicals are free radicals, whereas hydrogen peroxide is a non-radical ROS. Low levels of ROS participate in cellular signaling. Oxidative stress develops when the production of oxidizing species continuously exceeds the cell’s capacity for clearance and repair.

The principal mechanisms through which ergothioneine participates in redox regulation include:

 

Level of Action

Main Process

Type of Evidence

Free-radical-related electron transfer

Ergothioneine can undergo one-electron oxidation by certain highly reactive radicals, producing short-lived oxidation intermediates

In vitro pulse-radiolysis studies

Control of metal-catalyzed oxidation

Ergothioneine coordinates with Cu⁺, reducing the ability of copper to participate in redox cycling

In vitro chemical studies

Regulation of endogenous cellular defenses

In UVA-treated skin-cell models, ergothioneine is associated with Nrf2–ARE activation, increased GCLC expression, and elevated GSH levels

Skin-cell studies

 

3.1 Electron Transfer with Certain Highly Reactive Radicals

Pulse-radiolysis experiments have shown that hydroxyl radicals, azide radicals, and trichloromethylperoxyl radicals can induce one-electron oxidation of ergothioneine. In this process, ergothioneine loses a net electron and forms a short-lived oxidation intermediate.[9]

This finding indicates that ergothioneine can participate in electron-transfer reactions initiated by specific radicals. Its activity is selective; it does not scavenge all reactive oxygen species and cannot replace endogenous antioxidant enzymes such as catalase, glutathione peroxidase, and peroxiredoxins.

 

3.2 Coordination with Cu⁺ and Reduction of Copper-Catalyzed Oxidation

Copper ions can cycle between Cu²⁺ and Cu⁺ and can promote oxidative reactions in the presence of ascorbate or peroxides. In vitro experiments have shown that ergothioneine can form a coordination complex with Cu⁺ that has relatively low redox activity, thereby reducing copper-catalyzed ascorbate oxidation, DNA strand breakage, and protein carbonyl formation.[10]

 

The process can be summarized as follows:

Ergothioneine coordinates with Cu⁺

→ the ability of copper to participate in redox cycling decreases → copper-catalyzed oxidation is attenuated

This mechanism is derived from in vitro chemical studies and cannot be used to determine the actual abundance or physiological role of ergothioneine–copper complexes in human skin cells.

 

3.3 Activation of Nrf2–ARE-Related Defenses and Support of Glutathione Synthesis

After entering the nucleus, nuclear factor erythroid 2-related factor 2 (Nrf2) can bind to antioxidant response elements (AREs) and promote the expression of genes involved in antioxidant defense and detoxification.

 

In UVA-treated HaCaT keratinocytes, treatment with 125–500 nmol/L ergothioneine was associated with the following changes:[7]

① Increased nuclear accumulation of Nrf2 and ARE transcriptional activity;

② Increased expression of heme oxygenase-1 (HO-1);

③ Increased expression of NAD(P)H quinone oxidoreductase 1 (NQO1);

④ Increased expression of the glutamate-cysteine ligase catalytic subunit (GCLC);

⑤ Increased intracellular levels of reduced glutathione (GSH).

 

The principal relationships are:

Nrf2 nuclear translocation → ARE activation → increased expression of HO-1, NQO1, and GCLC

Of these:

Increased GCLC expression → enhanced glutathione-synthesis capacity → strengthened cellular reducing defense

 

HO-1 and NQO1 represent other branches of Nrf2-regulated defense and do not directly participate in glutathione synthesis. After Nrf2 or OCTN1 knockdown, the inhibitory effects of ergothioneine on UVA-induced increases in ROS, apoptosis, and cell death were weakened. This indicates that both OCTN1-mediated cellular uptake and Nrf2-related signaling contribute to the protective effects observed in this cell model.[7]

 

4. Effects of the Antioxidant Network on Skin Cells

 

4.1 Keratinocytes: Reduced Oxidative Damage and Apoptotic Signaling

Keratinocytes are located in the viable epidermis and are among the first living skin cells to encounter ultraviolet radiation and environmental oxidative stimuli. UVA can increase intracellular ROS, damage DNA, proteins, and lipids, and affect mitochondrial membrane function and apoptotic pathways.

In experiments using HaCaT keratinocytes, ergothioneine pretreatment attenuated the damage caused by 15 J/cm² UVA. The study observed reduced ROS generation, less DNA damage as indicated by the comet assay, reduced mitochondrial dysfunction, decreased activation of caspase-9 and caspase-3, attenuation of the Bcl-2/Bax imbalance, and increased cell viability.[7]

These findings were obtained from cultured-cell models and cannot be directly equated with the efficacy of topically applied products in human skin.

 

4.2 Fibroblasts: AP-1, MMP-1, and Type I Procollagen

UVA-induced ROS can activate multiple protein kinase pathways and promote activation of c-Fos and c-Jun, the components of activator protein 1 (AP-1). AP-1 can promote the expression of matrix metalloproteinase 1 (MMP-1). MMP-1 participates in the initial cleavage of type I and type III fibrillar collagen and is an important contributor to ultraviolet-associated extracellular-matrix degradation.

 

In experiments using UVA-treated human dermal fibroblasts, treatment with 0.125–0.5 μmol/L ergothioneine was associated with the following changes:

 

Observed Parameter

Experimental Result

UVA-induced ROS

Decreased

Nuclear translocation of c-Fos and c-Jun

Attenuated

AP-1 activation

Attenuated

MMP-1 activation

Decreased

Type I procollagen degradation

Reduced

Nrf2-related antioxidant proteins

Increased

Intracellular GSH

Increased

 

These results indicate that, in this cell model, ergothioneine may reduce type I procollagen degradation by lowering oxidative pressure and suppressing AP-1–MMP-1 signaling.[8]

 

4.3 Preliminary Evidence Relating to the Common 4,977-bp mtDNA Deletion

Mitochondrial DNA (mtDNA) is located in the mitochondrial matrix, close to the electron-transport chain of the inner mitochondrial membrane. Persistent oxidative stress can increase damage to mtDNA bases and strand structure. The 4,977-bp deletion is commonly referred to as the mtDNA “common deletion” and may serve as an indicator of mitochondrial damage in certain photoaging studies.

 

A preliminary study published in 2014 used primary human dermal fibroblasts from four donors. The cells were repeatedly exposed to UVA over a three-week period, and the 4,977-bp mtDNA deletion was detected using polymerase chain reaction. The experiment used 20 μmol/L ergothioneine and also measured cellular GSH levels.[12]

The study observed the 4,977-bp deletion in some untreated UVA-exposed samples, whereas the deletion was not detected in the corresponding ergothioneine-treated samples. Ergothioneine treatment was also accompanied by increased GSH levels.[12]

 

The study included only a small number of samples, and the common deletion was successfully induced in only some untreated samples. The available results support the possibility that ergothioneine may reduce the formation of the common 4,977-bp mtDNA deletion in this specific UVA model. They do not support the conclusion that ergothioneine can replace already deleted DNA fragments or repair pre-existing mtDNA mutations.

 

4.4 Supplementary Evidence from Animal Experiments

A 2024 study involving ultraviolet-exposed mice and cultured cells found that ergothioneine treatment was associated with reduced markers of oxidative skin damage, improved antioxidant enzyme activity, decreased matrix metalloproteinase levels, and changes in PI3K/Akt/Nrf2-related signaling.[13]

 

5. Redox Interactions Between Ergothioneine and Vitamin C

 

Ergothioneine and vitamin C can both participate in aqueous-phase redox reactions, but they perform different roles. Under physiological conditions, vitamin C exists mainly as ascorbate and can rapidly donate electrons. Ergothioneine has a relatively stable thione structure, OCTN1-mediated cellular uptake capacity, and the ability to coordinate with Cu⁺.

 

5.1 Vitamin C Reduces the One-Electron Oxidation Intermediate of Ergothioneine

After ergothioneine reacts with certain strongly oxidizing radicals, it can form a one-electron oxidation intermediate. In vitro pulse-radiolysis studies have shown that ascorbate can donate an electron to this intermediate, restoring ergothioneine to its reduced state while forming an ascorbyl radical.[9]

 

The process can be simplified as follows:

Oxidizing species + EGT

→ one-electron oxidation intermediate of EGT

 

One-electron oxidation intermediate of EGT + ascorbate

→ regeneration of reduced EGT + ascorbyl radical

The second-order rate constant for this reaction is approximately 6.3 × 10⁸ L·mol⁻¹·s⁻¹, indicating that the reaction proceeds rapidly under the corresponding in vitro conditions.[9]

 

5.2 GSH, NADPH, and NADH Support Vitamin C Regeneration

After donating an electron, ascorbate can form an ascorbyl radical and may subsequently be converted into dehydroascorbic acid (DHA). These oxidized forms must be converted back into ascorbate through cellular reducing systems.

 

Studies in human endothelial cells have shown that:

① Ascorbyl radicals can be reduced through mechanisms dependent on reduced nicotinamide adenine dinucleotide (NADH) and reduced nicotinamide adenine dinucleotide phosphate (NADPH);

② Reduction of DHA requires GSH and can occur through both direct and enzyme-mediated reactions;

③ Oxidized glutathione (GSSG) can be reduced to GSH by glutathione reductase using NADPH.[11]

 

The principal electron flows can be represented as follows:

DHA

—GSH and related reductive mechanisms→ ascorbate

 

GSSG

—glutathione reductase and NADPH→ GSH

 

These mechanisms were identified in studies of human endothelial cells and their cell lysates. They describe the basic cellular reducing processes required for vitamin C regeneration, but do not constitute direct validation of an ergothioneine–vitamin C combination in skin cells.

 

5.3 Their Redox Relationship Is Part of a Multicomponent Reducing Network

Experimentally supported links between ergothioneine and vitamin C include two directions:

 

Vitamin C donates electrons

→ regeneration of the one-electron oxidation intermediate of ergothioneine

 

Ergothioneine binds Cu⁺

→ reduction of copper-catalyzed vitamin C oxidation

 

Vitamin C itself requires support from GSH, NADPH, NADH, and related reductases for regeneration. The relevant electron-transfer relationships can be summarized as interconnected reducing processes:

NADPH can support GSH regeneration through glutathione reductase; NADH- or NADPH-dependent mechanisms can participate in the reduction of ascorbyl radicals; GSH and related reductive mechanisms can reduce dehydroascorbic acid to ascorbate; and regenerated ascorbate can donate electrons in vitro to the one-electron oxidation intermediate of ergothioneine. Ergothioneine and vitamin C participate together in a multicomponent redox network.[9–11]

 

6. From Mechanism of Action to Topical Formulation

 

6.1 Raw-Material Identity and Quality

Natural extraction, microbial fermentation, enzyme catalysis, and chemical synthesis may produce different impurity profiles. The source of a raw material alone does not determine its efficacy. Chemical identity, purity, stability, and actual use level have a more direct influence on research and formulation outcomes.

 

6.2 Formulation Concentration Does Not Equal Intracellular Concentration

Topically applied ergothioneine must pass through the following steps:

Release from the formulation → entry into the stratum corneum → arrival at the viable epidermis → uptake into cells through OCTN1 → intracellular accumulation

The labeled concentration in a formulation cannot be directly converted into the concentration inside viable epidermal cells. Ex vivo skin-distribution studies, skin-penetration studies, or other appropriate delivery studies can be used to determine whether ergothioneine reaches the viable cellular environment in which OCTN1 is present.

 

6.3 Stability Must Be Verified When Combined with Vitamin C

Ergothioneine and ascorbate have an in vitro basis for redox interactions, but finished-product stability is also influenced by the following factors:

① Whether L-ascorbic acid or a vitamin C derivative is used;

② Formulation pH;

③ Trace metals such as iron and copper;

④ Dissolved oxygen and filling conditions;

⑤ Light exposure and storage temperature;

⑥ The light-protective and oxygen-barrier properties of the packaging;

⑦ Changes in content, color, odor, and pH after opening.

Vitamin C derivatives must undergo the corresponding conversion and release redox-active ascorbate before they can directly participate in reducing the one-electron oxidation intermediate of ergothioneine.

 

6.4 Different Experiments Answer Different Questions

 

Level of Research

Main Question Addressed

Chemical reaction experiments

Whether the ingredient reacts with specific radicals, oxidation intermediates, or metal ions

Transport studies

Whether OCTN1 mediates the entry of ergothioneine into cells

Skin-cell studies

Whether the ingredient affects ROS, Nrf2, GSH, AP-1, or MMP-1

Ex vivo skin studies

Whether the ingredient enters the stratum corneum or reaches the viable epidermis

Finished-product stability studies

Whether the active ingredient remains stable during storage and use

Human efficacy trials

Whether actual use improves the target skin parameters

 

Raw-material chemical experiments and cultured-cell studies cannot replace human efficacy studies of the final formulation. If the formulation composition, concentration, delivery method, or duration of use changes, the finished product must be validated again.

 

7. Representative Categories and Research Applications of Chemicals Related to Studies of Ergothioneine Structure, Biosynthesis, OCTN1 Transport, Antioxidant Networks, and Mitochondrial Photodamage

 

Table 1. Products Related to Core Ergothioneine Compounds, Biosynthetic Precursors, and Sulfur Metabolism

 

Category

CAS No.

Aladdin Catalog No.

Name

Specification or Purity

Product Features and Applications

Core ergothioneine compound

497-30-3

L134175

L-(+)-Ergothioneine

Moligand™, ≥98%

Used in studies of the structural properties of ergothioneine, OCTN1-mediated uptake, intracellular accumulation, ultraviolet-induced oxidative stress, and skin-cell protection.

Direct biosynthetic precursor of ergothioneine

534-30-5

P770483

Histidine Betaine

Moligand™, ≥97%

Used in studies of ergothioneine biosynthesis, histidine trimethylation, precursor conversion, metabolite identification, and structural controls.

Histidine-skeleton precursor of ergothioneine

71-00-1

H108261

L-Histidine

Animal-origin-free, USP, Moligand™, European Pharmacopoeia (Ph. Eur.), for cell culture

Used in studies of the histidine-skeleton origin of ergothioneine, histidine betaine formation, fermentation-substrate supply, and biosynthetic pathways.

Biosynthetic methyl donor

29908-03-0

S192607

S-Adenosyl-L-methionine (SAM)

Moligand™, ≥98%

Used in studies of histidine trimethylation during ergothioneine biosynthesis, methyltransferase reactions, and evaluation of fermentation pathways.

Precursor in the methyl-donor cycle

63-68-3

M101131

L-Methionine (H-Met-OH)

Animal-origin-free, USP, JP, Moligand™, European Pharmacopoeia (Ph. Eur.), for cell culture, ≥99%

Used for S-adenosylmethionine supply, regulation of the methyl cycle, ergothioneine fermentation media, and metabolic-flux studies.

Sulfur-containing precursor and glutathione substrate

52-90-4

C108238

L-Cysteine

Animal-origin-free, Moligand™, for cell culture, ≥98%

Used for sulfur-containing precursor supply, glutathione synthesis, screening of ergothioneine biosynthetic conditions, and redox-control studies.

Substrate for glutathione synthesis

56-86-0

G103978

L-Glutamic Acid

≥99%

Used in studies of γ-glutamyl metabolism, glutathione synthesis, and ergothioneine-related cellular reducing systems.

Substrate for glutathione synthesis

56-40-6

A110751

Glycine

PharmPure™, USP, BP, European Pharmacopoeia (Ph. Eur.), ≥99%

Used in glutathione synthesis, amino-acid composition of culture media, and evaluation of antioxidant capacity in skin cells.

Cysteine donor and antioxidant control

616-91-1

A105421

N-Acetyl-L-cysteine (NAC)

PharmPure™, USP, Moligand™, European Pharmacopoeia (Ph. Eur.), ≥98.5%

Used to supplement cysteine, support glutathione synthesis, establish antioxidant positive controls, and study ultraviolet-induced oxidative stress.

 

Table 2. Products Related to the Vitamin C–Glutathione–Cellular Reducing-Equivalent Network

 

Category

CAS No.

Aladdin Catalog No.

Name

Specification or Purity

Product Features and Applications

Vitamin C electron donor

50-81-7

L432793

L-Ascorbic Acid

Anhydrous grade, Moligand™, ACS, ≥99%

Used in studies of reduction of the one-electron oxidation intermediate of ergothioneine, synergistic antioxidant effects of vitamin C, collagen hydroxylation, and ultraviolet-damage controls.

Vitamin C salt form and cell-culture control

134-03-2

S105026

Sodium Ascorbate

For cell culture, ≥99%

Used for aqueous-phase vitamin C supply, antioxidant controls in cell culture, and evaluation of ergothioneine–ascorbate synergy.

Vitamin C oxidation product

490-83-5

L1374153

(L)-Dehydroascorbic Acid

Moligand™, ≥95%

Used in studies of vitamin C oxidation, glutathione-dependent regeneration, cellular uptake, and redox cycling.

Reduced glutathione

70-18-8

G774620

Glutathione, Reduced

PharmPure™, European Pharmacopoeia (Ph. Eur.)

Used in dehydroascorbic acid reduction, peroxide treatment, cellular thiol protection, and studies of ergothioneine-related antioxidant networks.

Oxidized glutathione

27025-41-8

G640155

L-Glutathione, Oxidized

Animal-origin-free, low endotoxin, for cell culture, ≥98%

Used in studies of the glutathione redox couple, glutathione reductase reactions, cellular redox status, and oxidative-stress evaluation.

Reducing equivalent for glutathione regeneration

2646-71-1

N1510346

Reduced Coenzyme II Tetrasodium Salt Hydrate (β-NADPH Tetrasodium Salt Hydrate)

≥99%

Used for reduction of oxidized glutathione, indirect regeneration of vitamin C, reductase systems, and studies of electron flow in cellular antioxidant networks.

Cellular reducing equivalent

606-68-8

N106933

Reduced Coenzyme I Disodium Salt (β-NADH)

≥98%

Used as an electron donor for reductases and in studies of ascorbyl-radical reduction and cellular redox metabolism.

 

Table 3. Products Related to Metal-Catalyzed Oxidation, Antioxidant-Capacity Evaluation, and Oxidative-Damage Detection

 

Category

CAS No.

Aladdin Catalog No.

Name

Specification or Purity

Product Features and Applications

Divalent-copper oxidation-reaction model

7758-99-8

C112411

Copper(II) Sulfate Pentahydrate

For cell culture, ≥98%

Used in copper–ascorbate oxidation systems and studies of ergothioneine–copper coordination, metal-catalyzed reactive oxygen species generation, and cellular oxidative stress.

Monovalent-copper coordination model

7758-89-6

C112392

Copper(I) Chloride

PrimorTrace™, ≥99.999% metals basis

Used in studies of ergothioneine coordination with Cu⁺, copper-catalyzed vitamin C oxidation, and metal redox activity.

Divalent-iron oxidation-reaction model

7782-63-0

F116341

Iron(II) Sulfate Heptahydrate

Suitable for plant cell culture, ≥99%

Used in Fenton-reaction studies, hydroxyl-radical generation, iron-catalyzed oxidative damage, and metal-control comparisons involving ergothioneine.

Metal-chelation control

6381-92-6

E433190

Ethylenediaminetetraacetic Acid Disodium Salt Dihydrate

UltraBio™, ultrapure grade, ≥98.5%

Used for transition-metal chelation, inhibition of metal-catalyzed oxidation, and control studies of ergothioneine-mediated metal coordination.

High-affinity metal-chelation control

67-43-6

D108513

Diethylenetriaminepentaacetic Acid (DTPA)

AR, ≥99% (T)

Used for iron- and copper-ion control, metal-dependent oxidation reactions, and elimination of background interference in antioxidant experiments.

Peroxide oxidative-stress model

7722-84-1

H755825

Hydrogen Peroxide Solution

Suitable for microbiology, 3%

Used to establish models of oxidative stress in skin cells, Nrf2-mediated defense, mitochondrial damage, and antioxidant protection.

Redox-cycling inducer

58-27-5

M432986

Menadione

Crystalline

Used to induce intracellular redox cycling, increased reactive oxygen species, glutathione depletion, and mitochondrial stress.

Peroxyl-radical generator

2997-92-4

A101386

2,2′-Azobis(2-methylpropionamidine) Dihydrochloride (AAPH)

≥97%

Used to continuously generate peroxyl radicals and evaluate the radical-reactivity of ergothioneine and its protective effects against lipid oxidation.

Radical-cation antioxidant evaluation

30931-67-0

A109612

2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic Acid) Diammonium Salt [AzBTS-(NH₄)₂]

≥98%

Used in radical-cation scavenging, total antioxidant-capacity assays, and comparative studies of ergothioneine and vitamin C.

Stable-radical antioxidant evaluation

1898-66-4

D141336

2,2-Diphenyl-1-picrylhydrazyl (Contains 10–20% Benzene)

≥97% (HPLC)

Used in stable-radical scavenging, evaluation of electron- or hydrogen-donor capacity, and chemical antioxidant screening of ergothioneine.

Ferric-ion-reducing-capacity evaluation

3682-35-7

T106623

2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ)

≥99%

Used in ferric-reducing antioxidant-capacity assays, standard-curve establishment, and comparison of different antioxidant ingredients.

Water-soluble vitamin E analog reference

53188-07-1

T137260

Trolox

≥98%, white

Used for standard curves in total antioxidant-capacity assays, as a free-radical-scavenging reference, and for conversion and comparison of results obtained using different analytical methods.

Fluorescent probe for intracellular oxidative reactions

4091-99-0

H131224

2′,7′-Dichlorodihydrofluorescein Diacetate (DCFH-DA)

≥97%

Used to evaluate overall intracellular oxidative-reaction signals, ultraviolet-induced oxidative stress, and the protective effects of ergothioneine.

Superoxide-anion-related fluorescent probe

104821-25-2

D113494

Dihydroethidium

≥95%

Used to assess intracellular superoxide-anion-related signals, oxidative-stress localization, and the antioxidant effects of ergothioneine.

Oxidative DNA-damage marker

88847-89-6

H136806

2′-Deoxy-7,8-dihydro-8-oxoguanosine

≥95% (HPLC)

Used as a standard for oxidative DNA damage, for establishing chromatographic or immunoassay methods, and for evaluating ultraviolet-induced damage.

Protein-carbonyl detection reagent

119-26-6

D489117

2,4-Dinitrophenylhydrazine

Reagent grade, ≥97%

Used for protein-carbonyl derivatization, oxidized-protein detection, and evaluation of the protein-protective effects of ergothioneine.

Lipid-peroxidation detection reagent

504-17-6

T108505

2-Thiobarbituric Acid

Moligand™, ≥98%

Used in thiobarbituric-acid-reactive-substance assays, malondialdehyde-related lipid-peroxidation analysis, and antioxidant evaluation.

Malondialdehyde-standard precursor

122-31-6

T106807

1,1,3,3-Tetraethoxypropane

≥97%

Used to prepare malondialdehyde standard solutions, establish lipid-peroxidation standard curves, and quantify ultraviolet-induced oxidative damage.

Thiol and glutathione detection reagent

69-78-3

D105559

5,5′-Dithiobis(2-nitrobenzoic Acid) (DTNB)

≥98%

Used to measure free thiols, total thiols, and glutathione-related parameters and to evaluate the cellular redox status after ergothioneine treatment.

 

Table 4. Products Related to Research on the Nrf2–MAPK/AP-1–MMP Signaling Pathways

 

Category

CAS No.

Aladdin Catalog No.

Name

Specification or Purity

Product Features and Applications

Nrf2 functional-inhibition control

846557-71-9

M304758

ML385, Nrf2 Inhibitor

Moligand™, ≥99%

Used to verify the dependence of the antioxidant effects of ergothioneine on Nrf2 and to assess changes in HO-1, NQO1, GCLC, and glutathione.

Positive control for Nrf2 activation

4478-93-7

S111997

Sulforaphane

Moligand™, ≥95%

Used as a positive control in studies of Nrf2 nuclear translocation, antioxidant response element activation, and endogenous antioxidant-gene expression.

Nrf2/ARE induction control

1948-33-0

B105351

tert-Butylhydroquinone (TBHQ)

≥98%

Used to induce the Nrf2/ARE pathway and antioxidant-enzyme expression and to compare the cellular defense effects of ergothioneine.

JNK/AP-1 pathway inhibitor

129-56-6

S125267

Anthra[1,9-cd]pyrazol-6(2H)-one

Moligand™, ≥98%

Used to inhibit JNK and c-Jun activation and to study ultraviolet-induced AP-1, MMP-1, and collagen-degradation signaling.

p38 MAPK pathway inhibitor

152121-47-6

S131899

SB-203580, p38 MAPK Inhibitor

Moligand™, ≥98% (HPLC)

Used to investigate p38 MAPK-mediated oxidative stress, AP-1 activation, inflammatory responses, and MMP-1 expression.

Matrix-metalloproteinase inhibition control

142880-36-2

G274767

GM 6001, Broad-Spectrum MMP Inhibitor

Moligand™, ≥98%

Used to inhibit matrix-metalloproteinase activity, evaluate collagen degradation, and distinguish upstream antioxidant effects from downstream changes in enzyme activity.

 

Table 5. Products Related to the Evaluation of Mitochondrial Oxidative Stress, Respiratory Function, and Membrane Potential

 

Category

CAS No.

Aladdin Catalog No.

Name

Specification or Purity

Product Features and Applications

Mitochondria-targeted antioxidant control

1334850-99-5

M414479

Mito-TEMPO

Moligand™, ≥98%

Used as a control for the inhibition of mitochondrial oxidative stress and superoxide-anion scavenging and for comparison with the mitochondrial protective effects of ergothioneine.

Mitochondrial complex I inhibition model

83-79-4

R105076

Rotenone

Moligand™, ≥95%

Used to inhibit mitochondrial complex I and induce respiratory-chain electron leakage, superoxide-anion generation, and abnormal membrane potential.

ATP synthase inhibition model

579-13-5

O102388

Oligomycin A from Streptomyces diastatochromogenes

EnzymoPure™, ≥97%

Used to inhibit mitochondrial ATP synthase and evaluate ATP-linked respiration, proton re-entry, and the protective effects of ergothioneine on energy homeostasis.

Oxidative-phosphorylation uncoupler

370-86-5

C169970

Carbonyl Cyanide 4-(Trifluoromethoxy)phenylhydrazone (FCCP)

Moligand™, ≥98% (TLC)

Used to induce mitochondrial-membrane-potential depolarization, measure maximal respiratory capacity, and serve as a positive control for membrane-potential probes.

Fluorescent probe for mitochondrial membrane potential

115532-50-8

T768877

Tetramethylrhodamine Methyl Ester Perchlorate (TMRM Perchlorate)

BioReagent, biological stain, suitable for fluorescence analysis and microscopy, ≥95%

Used for dynamic detection of mitochondrial membrane potential, ultraviolet-induced depolarization, and evaluation of the protective effects of ergothioneine on mitochondrial function.

Ratiometric probe for mitochondrial membrane potential

3520-43-2

J125134

JC-1, Mitochondrial Membrane-Potential Dye

≥95%

Used to assess changes in mitochondrial membrane potential, the fluorescence ratio between aggregate and monomer forms, and mitochondrial-pathway apoptosis.

Fluorescent probe for mitochondrial superoxide

1003197-00-9

M647069

MitoSOX Red, Mitochondrial Superoxide Red Fluorescent Probe

≥95%

Used to detect mitochondrial superoxide-anion-related signals and evaluate respiratory-chain oxidative stress and the protective effects of ergothioneine.

 

Note: The products listed above are representative Aladdin products related to scientific research. Their specific uses should be determined according to the product specifications, batch certificate of analysis (COA), and the target reaction or evaluation system. Additional product specifications, grades, and COA information can be retrieved from the Aladdin website using the product name, CAS number, or catalog number.

 

References

 

[1] National Center for Biotechnology Information. PubChem Compound Summary for CID 5351619, Ergothioneine. PubChem. Accessed August 5, 2026.

 

[2] Seebeck FP. In vitro reconstitution of mycobacterial ergothioneine biosynthesis. J Am Chem Soc. 2010;132(19):6632–6633. doi:10.1021/ja101721e.

 

[3] Cumming BM, Chinta KC, Reddy VP, Steyn AJC. Role of ergothioneine in microbial physiology and pathogenesis. Antioxid Redox Signal. 2018;28(6):431–444. doi:10.1089/ars.2017.7300.

 

[4] Cheah IK, Halliwell B. Ergothioneine, recent developments. Redox Biol. 2021;42:101868. doi:10.1016/j.redox.2021.101868.

 

[5] Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Schömig E. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A. 2005;102(14):5256–5261. doi:10.1073/pnas.0408624102.

 

[6] Markova NG, Karaman-Jurukovska N, Dong KK, Damaghi N, Smiles KA, Yarosh DB. Skin cells and tissue are capable of using L-ergothioneine as an integral component of their antioxidant defense system. Free Radic Biol Med. 2009;46(8):1168–1176. doi:10.1016/j.freeradbiomed.2009.01.021.

 

[7] Hseu YC, Lo HW, Korivi M, Tsai YC, Tang MJ, Yang HL. Dermato-protective properties of ergothioneine through induction of Nrf2/ARE-mediated antioxidant genes in UVA-irradiated human keratinocytes. Free Radic Biol Med. 2015;86:102–117. doi:10.1016/j.freeradbiomed.2015.05.026.

 

[8] Hseu YC, Gowrisankar YV, Chen XZ, Yang YC, Yang HL. The antiaging activity of ergothioneine in UVA-irradiated human dermal fibroblasts via the inhibition of the AP-1 pathway and the activation of Nrf2-mediated antioxidant genes. Oxid Med Cell Longev. 2020;2020:2576823. doi:10.1155/2020/2576823.

 

[9] Asmus KD, Bensasson RV, Bernier JL, Houssin R, Land EJ. One-electron oxidation of ergothioneine and analogues investigated by pulse radiolysis: redox reaction involving ergothioneine and vitamin C. Biochem J. 1996;315(Pt 2):625–629. doi:10.1042/bj3150625.

 

[10] Zhu BZ, Mao L, Fan RM, Zhu JG, Zhang YN, Wang J, Kalyanaraman B, Frei B. Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. Chem Res Toxicol. 2011;24(1):30–34. doi:10.1021/tx100214t.

 

[11] May JM, Qu ZC, Neel DR, Li X. Recycling of vitamin C from its oxidized forms by human endothelial cells. Biochim Biophys Acta. 2003;1640(2–3):153–161. doi:10.1016/S0167-4889(03)00043-0.

 

[12] Bazela K, Sołyga-Żurek A, Dębowska R, Rogiewicz K, Bartnik E, Eris I. L-Ergothioneine protects skin cells against UV-induced damage—A preliminary study. Cosmetics. 2014;1(1):51–60. doi:10.3390/cosmetics1010051.

 

[13] Li Y, Gao J, Liu S, Chen S, Wei X, Guan Y, Li X, Li Y, Huang Z, Li G, Zhao Y, Liu P, Zhang Y. Ergothioneine protects against UV-induced oxidative stress through the PI3K/AKT/Nrf2 signaling pathway. Clin Cosmet Investig Dermatol. 2024;17:1309–1319. doi:10.2147/CCID.S449987.

 

[14] Sato S, Saika A, Koshiyama T, Higashiyama Y, Fukuoka T, Morita T. Biosynthesis of ergothioneine: current state, achievements, and perspectives. Appl Microbiol Biotechnol. 2025;109:93. doi:10.1007/s00253-025-13476-4.

 

For more related articles, see below:

 

Analysis of Hydrolyzed Pearl as a Cosmetic Raw Material: Preparation Process, Active Components, and Skincare Formulation Applications

 

The Dual-Targeted Skin-Brightening Mechanism of 4-MSK: Inhibiting Melanin Production and Reducing Epidermal Pigment Retention

 

Antioxidant Mechanisms, Stability, and Delivery Strategies of Resveratrol in Skincare Research

 

Antioxidant Mechanisms of Ferulic Acid in Skincare, Vitamin C/E Synergy, and Stable Delivery Applications

 

Tocopherols in the Vitamin E Family: How They Block the Chain Reaction of Lipid Peroxidation in Skin Lipids

 

The Skin Anti-Aging Mechanisms of α-Lipoic Acid: ALA/DHLA Redox Cycling, the Antioxidant Network, and Regulation of Collagen AGE Formation

 

Mechanistic Analysis of Topical Glutathione in Skincare: Cellular Redox Regulation, Skin Delivery Challenges, and SLN-Based Delivery Strategies

 

Mechanism of Kojic Acid in Reducing Hyperpigmentation: From Tyrosinase Inhibition to Melanin Production Regulation

 

Beneath the Skin: Protein- and Peptide-Based Actives in Skincare and Aesthetic Medicine

 

Understanding Ceramides from the Perspective of the Stratum Corneum Lipid Barrier: Moisturizing and Barrier-Repair Mechanisms, Ingredient Selection, and Formulation Research Considerations

 

Hyaluronidase: Unlocking a “Magic Enzyme” in Biomedicine

 

Hyaluronan

 

Recombinant Humanized Type III Collagen: Structural Basis, Manufacturing Technologies, and Dermatological Applications

 

Trehalose: Physicochemical Characteristics, Manufacturing Processes, and Application Guidelines

 

Compounds found in Green Tea

 

Sources, Biological Functions, Isolation/Characterization, and Emerging Applications of Exosomes

 

Applicability Comparison of Vitronectin, Laminin and Fibronectin in Cell Culture Coating Systems

 

Cosmetic Peptides

 

Resveratrol

 

Ferulic Acid: Structural Features, Preparation Routes, and Key Points for Research Applications

 

Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling

 

Cosmetic Grade Explained

 

How to decipher the whitening code?

 

Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape

 

The "Six Key Checkpoints" of Skin Lightening

 

Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance

 

What is Glutathione?

目录: 技术文章
探索主题: EGT L-ergothioneine

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Structural Characteristics of Ergothioneine, OCTN1-Mediated Uptake by Skin Cells, and Antioxidant Mechanisms》. 阿拉丁知识库,更新于 2026年8月26日。 https://www.aladdin-e.com/zh_cn/faqs/structural-characteristics-of-ergothioneine-mediated-uptake-by-skin-cells-and-antioxidant-mechanisms-en.html
这篇文章对您有帮助吗? Yes No 有 5 人觉得有帮助